Both toxins play an important role in inducing muscular atrophy through various mechanisms (e.g., pro-inflammatory cytokines release or activation of some pathways, such as aryl hydrocarbon receptor (AhR), NFκB and SRAA) [11]. The gene discussed is AHR; the disease is muscular atrophy.